Senior Director, Search & Evaluation Late Ta Lead, Immunology

CSL Behring

Waltham, MA, US
Base: $308,000 - $377,000; bonus/equity: incentive...
Hybrid
15+ years biopharma experience
Deep clinical expertise immunology hematology
Proven track record closing late-stage deals
The role involves leading strategic sourcing and evaluation of later-stage external Hematology therapeutic assets from Phase 2 through marketed drugs

Job Summary

  • The role involves leading strategic sourcing and evaluation of later-stage external Hematology therapeutic assets from Phase 2 through marketed drugs.
  • Candidates must possess deep clinical expertise in Immunology, Hematology, or Cardiovascular/Renal areas along with a proven track record of closing late-stage deals.
  • CSL is a global biotherapeutics leader employing 32,000 people that delivers lifesaving therapies to more than 100 countries.

Matching Summary

The role involves leading strategic sourcing and evaluation of later-stage external Hematology therapeutic assets from Phase 2 through marketed drugs.

Salary

Base: $308,000 - $377,000; Bonus/Equity: Incentive compensation and equity included; Benefits: Not specified

Skills & Requirements

Must-have

  • 15+ years biopharma experience
  • Deep clinical expertise Immunology Hematology
  • Proven track record closing late-stage deals
  • Advanced degree MD or PhD required
  • Strong understanding regulatory pathways market access

Nice-to-have

  • Experience engaging Key Opinion Leaders networks
  • Ability to anticipate competitive dynamics
  • Strategic portfolio planning influence
  • Cross-functional team leadership skills
  • Agile team collaboration mindset

Key Requirements

  • 15+ years in biopharma
  • MD, PhD, or equivalent advanced degree
  • Deep clinical expertise in specified therapeutic areas
  • Proven deal sourcing and closing experience

Work Rights

Not specified

Tailored Resume

Cover Letter